PlainRecalls

Medaus, Inc.

Compiled from official public sources by the publisher.

96 recalls on record · Latest: Jul 20, 2016

Subscribe to new Medaus, Inc. recalls (RSS)

Agency notice ledger

Federal filing book Medaus, Inc. MID-BOOK · SINGLE-AGENCY

#173 of 14,151 · 96 notices · 0.092% archive

  • BOOK 96 notices
  • RANK #173 of 14,151
  • SHARE 0.092% archive
  • AGENCY FDA Drug (96)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 20, 2016
  • PHOTO CooperSurgical, Inc.

Nearest notice-volume peer: CooperSurgical, Inc. (1 notice gap)

Medaus, Inc. accounts for about 0.092% of the 104,423-notice archive on 96 distinct filings — a heavy share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Medaus, Inc.'s standing among 14,151 recalling firms

Medaus, Inc. ranks 173rd of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Medaus, Inc. vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

96 173rd of 14151 higher than 13,978 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Medaus, Inc. in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Medaus, Inc. holds about 0.092% of archive notices alongside 96 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jul 20, 2016

M.I.C B-COMPLEX PREMIX W/HYDROXY B12 W/PRES. (BENZALKONIUM 0.01%) HYDROXY B12 1MG; B1 0.833MG; B2 0.083MG; B3 0.833MG, B5 0.083MG, B6 0.083MG, CYANO B12 1.66MCG, METHIONINE 0.208MG, INOSITOL 0.416MG, CHOLINE CL 1.66MG/ML, 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

M.I.C 25/50/50 W/PRES. (BENZYL ETOH 2%) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50/MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

DEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

L-GLUTATHIONE 100MG/ML (PF), 10 ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

METHYL B12 10MG/ML (PF) IN NACL 0.9%, 1ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

L-CARNITINE 500MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO-INJECTION W/LIDOCAINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

MINOXIDIL 0.5% W/PRES. (BENZYL ETOH 2%), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

PYRIDOXAL 50 MG/THIAMINE 50 MG/LIDOCAINE 1% NS (PF), 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

ARGININE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

MANGANESE SO4 0.1MG/ML (PF), In a) 2MLVials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO #4 W/METHYL B12 500 MCG/ML/NO METHIONINE W/PRES (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;B3-30MG; B5-5MG;B6-5MG;METHYL B12 500 MCG; LIDOCAINE 10 MG; INOSITOL-25MG; CHOLINE CHL-25 MG/ML; 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HYDROXY B12 5MG/ML IN NACL 0.9% (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HYDROXY B12 1000MCG/ML IN NACL 0.9% (PF), 1ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO-BOOST W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-52MG, METHYL, B12-500MCG, CARNITINE 50 MG, METHIONINE 12.5MG, INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE 30MG/ML, In a) 3ML Vials and b) 5ML Vials, MEDAUS PHARMACY
FDA Drug Low Jul 20, 2016

PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

NANDROLONE DEC 200MG/ML W/PRES. (BENZYL ETOH 10%), In a) 2ML Vials, b) 4ML Vials, and c) 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HYDROXY B12 5MG/ML W/PRES (BENZALKONIUM 0.01%), 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HCL 2MG/ML (PF), 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

B-COMPLEX #3 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-100MG, B5-2MG, B6-2MG/ML, 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO W/LIDOCAINE #3 W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID 50MG; B1-50MG;B2-5-P04-5MG;D3-30MG; B5-5MG;B6-5MG;CYANO B12-1MG; METHIONINE 12.5MG; INOSITOL-25MG; CHOLINE CL-25 MG; LIDOCAINE 10MG/ML, In a) 5 ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

M.I.C. 25/50/50 (PF) METHIONINE 25MG;INOSITOL 50MG;CHOLINE CHL 50MG/ML, In 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

THIAMINE 100 MG/ML, 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIDOCAINE 2% (PF) IN NACL, 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

TESTOSTERONE CYP 20 MG/ML W/PRES (BENZYL ETOH 2%), In a) 1ML Vials and b) 3ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

PYRIDOXINE HCL 100MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

DMPS 50MG/ML (PF), 5ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

MOLYBDENUM 250MCG/ML (PF), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO-INJECTION W/METHYL B12 1 MG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-1MG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

TAURINE 50 MG/ML (PF), In a) 1ML Vials, b) 10ML Vials, and c) 20ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

L-PHENYLALANINE 15MG/ML (PF), 50ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

L-CARNITINE 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

ZINC SO4 10MG/ML (PF), Vials 2ML, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HYDROXY B12 1000MCG/ML W/PRES (BENZALKONIUM 0.01%), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO-INJECTION W/METHYL B12 500 MCG/CARNITINE/NO VIT C W/PRES. (BENZYL ETOH 2%) B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, CARNITINE 25MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

LIPO-INJECTION W/METHYL B12 500 MCG/ML W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PHOS-5MG, B-3-50MG, B5-5MG, B6-5MG, METHYL B12-500MCG, LIDOCAINE-10MG, METHIONINE 12.5 MG, INOSITOL 25MG, CHOLINE CHL 25MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

TMG 100 MG/ML (PF), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

ZINC CHLORIDE 10MG/ML IN NACL 0.29% (PF), 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

RIBOFLAVIN 10MG/ML (PF), In a) 1ML Vials and b) 2ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

TAURINE 50 MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY
FDA Drug Moderate Jul 20, 2016

L-CARNITINE 250MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

Medaus, Inc. carries an outsized archive share

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Medaus, Inc.? ▼
PlainRecalls indexes 96 distinct federal recall events naming Medaus, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Medaus, Inc. sit among other recalling firms? ▼
Medaus, Inc. ranks #173 of 14,151 by distinct recall-event count among 14,151 firms in this archive (99th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Medaus, Inc.'s notices? ▼
FDA Drug accounts for 96 of this firm's 96 indexed notices.
What product category dominates Medaus, Inc.'s filing book? ▼
Filings for Medaus, Inc. span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Medaus, Inc.: 96 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Medaus, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026